Contents
Current Pharmaceutical Design, Volume 14 - Number 17
Epidemiology of HCV Infection
, 14(17): 1646 - 1654V. Baldo, T. Baldovin, R. Trivello and A. Floreani
DOI: 10.2174/138161208784746770
HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations
, 14(17): 1655 - 1660A. Tramarin, N. Gennaro, F. A. Compostella, C. Gallo, L. J. Wendelaar Bonga and M. J. Postma
DOI: 10.2174/138161208784746833
Acute Hepatitis C: Clinical Aspects, Diagnosis, and Outcome of Acute HCV Infection
, 14(17): 1661 - 1665P. Fabris, V. M. Fleming, M. T. Giordani and E. Barnes
DOI: 10.2174/138161208784746789
Cellular Immunity and Acute Hepatitis C Infection
, 14(17): 1666 - 1677K. Fitzmaurice and P. Klenerman
DOI: 10.2174/138161208784746806
HCV and Autoimmunity
, 14(17): 1678 - 1685S. Ferri, L. Muratori, M. Lenzi, A. Granito, F. B. Bianchi and D. Vergani
DOI: 10.2174/138161208784746824
Therapy of Acute Hepatitis C: A Review of Literature
, 14(17): 1686 - 1689T. Santantonio and M. Fasano
DOI: 10.2174/138161208784746851
Acute HCV in HIV-Positive Individuals – A Review
, 14(17): 1690 - 1697M. Danta and G. M. Dusheiko
DOI: 10.2174/138161208784746761
Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
, 14(17): 1698 - 1722C. Diniz, F. Borges, L. Santana, E. Uriarte, J. M.A. Oliveira, J. Goncalves and P. Fresco
DOI: 10.2174/138161208784746842
Clinical Drugs that Interact with St. Johns Wort and mplication in Drug Development
, 14(17): 1723 - 1742Yuan Ming Di, Chun Guang Li, Charlie Changli Xue and Shu-Feng Zhou
DOI: 10.2174/138161208784746798
Webmaster Contact: info@benthamscience.net